fluorodeoxyglucose f18 has been researched along with Theca Cell Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bono, Y; Fujiwara, H; Iwadare, J; Mizumoto, Y; Nakamura, M; Obata, T | 1 |
| Hu, C; Peng, NJ; Su, HM; Tsay, DG | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Theca Cell Tumor
| Article | Year |
|---|---|
FDG-PET-positive ovarian thecoma with GLUT5 expression: Five cases.
Topics: Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 5; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postmenopause; Thecoma | 2017 |
Ovarian thecoma mimicking carcinoma on F-18 FDG PET in a postmenopausal woman with elevated CA-125.
Topics: Aged; CA-125 Antigen; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Postmenopause; Thecoma; Tomography, X-Ray Computed | 2011 |